Results

Total Results: 1,494 records

Showing results for "harms".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-nv-hap-protocol.pdf
    August 05, 2024 - How could interventions to prevent NV-HAP for inpatients prevent or mitigate harms? 2. … The purpose of this rapid review is to evaluate and synthesize the evidence on benefits 4 and harms … We will also identify and describe how these PSPs (a) may prevent or mitigate harms to patients; (b … • Length of stay (hospital and ICU) • Mortality • NV-HAP related rehospitalization • Unintended harms … details about the outcomes (e.g., definitions, incidence, prevalence, timing, severity), unintended harms
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
    December 01, 2012 - As such, it is likely inferior to factor Xa inhibitors in the balance of benefits and harms as well … The balance of benefits and harms from using enoxaparin versus another low molecular weight heparin … Harms were not assessed in these trials or observational studies. … The comparative balance of benefits and harms for dalteparin therapy versus placebo or control was … Harms were not assessed in these trials or observational studies. Key Question 7.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - i am just waiting to see how you deduce the no active treatment harms. and even how you define it since … the burden of migraine on qol, economics etc are certainly harms that are not benefited by no active … Events in Migraine Trials of the International Headache Society86 when examining the potential harms … Long-term harms can be detected at years of followup. … Based on these known adverse events the conclusion that beta blockers are without bothersome harms
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
    April 01, 2025 - Future research is needed to assess the effectiveness of relevant interventions and unintended harms … How could supply chain disruption monitoring programs prevent or mitigate harms? … How could supply chain disruption monitoring programs prevent or mitigate harms? 2. … How Could Supply Chain Disruption Monitoring Programs Prevent or Mitigate Harms? … As there are currently no studies assessing the benefits and potential harms of implementing supply
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - The systematic review synthesizes evidence on the benefits and harms of plant-based compounds (PBCs … Comparable THC to CBD Ratio Benefits and Harms Benefits: small improvements in pain severity and … Extracted Whole- Plant High THC to CBD Ratio Benefits and Harms Benefits: insufficient evidence … Tables 3 and 4 summarize benefits and harms of cannabinoids. … We do not anticipate excluding observational studies assessing harms.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
    April 01, 2023 - by identifying characteristics of telehealth delivery, patient populations, settings, benefits and harms … need agreement on common outcomes and goals for P-P telehealth interventions so interventions and harms … coercive control, self-efficacy, post-traumatic stress disorder, and safety behaviors; the evidence on harms … to understand the impact of telehealth on patient engagement, access to care, health equity, and harms
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
    May 01, 2012 - because the celecoxib users would be more likely to be incident users at higher risk of any early harms … episodically (e.g., cycles of chemotherapy) and they wish to capture the totality of benefits and harms … incident users during 1999 through 2001 may have had past episodes of naproxen use and survived any harms … Physicians’ Health Study was a randomized controlled trial designed to evaluate the benefits and harms … A related point is that data sources may include too few events—benefits or harms—even if they include
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - For patients with chronic venous leg ulcers, what are the benefits and harms of surgical procedures … For patients with chronic venous leg ulcers, what are the comparative benefits and harms of different … Harms for topical antibiotics contained in dressings (KQ 1) a. … Harms for systemic antibiotics (KQ 2) a. Allergic and hypersensitivity reactions b. … Harms for surgical interventions (KQ3) a. Surgical site infection b. Bleeding c.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - KQ 3: What are the comparative benefits and harms of different contrast media in patients receiving … How do benefits or harms differ by the dose of contrast medium (i.e., by volume of dose and number … How do benefits or harms of contrast media differ according to the type of preventive strategy used? … KQ 4: What are the comparative benefits and harms of different contrast media in patients receiving … How do benefits or harms of contrast media differ according to the type of preventive strategy used?
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
    February 01, 2014 - Included adherence and harms outcomes—adherence, serious adverse events (as reported by investigators … Included FDA reports (SAE and harms only). Excluded studies with other observational designs. … with hyperlipidemia, and most were designed to evaluate effects on lipid measures and short-term harms … Additional studies evaluating long-term clinical benefits and harms are needed to better inform clinical … Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for
  11. Hi Les, (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
    January 01, 2009 - patients to the new test strategy or current best practice provide ideal evidence of the net benefits or harms … McCaffery among these White Papers and in Medical Decision Making.5) The incremental benefits and harms … When do we need long-term RCTs to assess trade-offs between the benefits and harms of a new test? … the feasibility of a long-term RCT, both practical and ethical, to quantify all the benefits and harms … Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
  12. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ems-911-workforce-protocol.pdf
    January 01, 2015 - What are the characteristics and reported effectiveness (i.e., benefits and harms) in studies of EMS … What is the reported effectiveness (i.e. benefits and harms) in studies of EMS/911 workforce practices … What are the characteristics and reported effectiveness (i.e., benefits and harms) in studies of EMS … What is the reported effectiveness (i.e., benefits and harms) in studies of EMS/911 workforce practices
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0274_03-10-2008.pdf
    January 01, 2008 - a clinical effectiveness review that evaluates expanded indications and includes health outcomes, harms
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - The original 2020 report examined the evidence on the comparative effectiveness and harms of opioids … harms, infections, cardiovascular events, cognitive harms, and psychological harms (e.g., depression … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … Misuse, opioid use disorder, overdose and other harms KQ2.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - The systematic review synthesizes evidence on the benefits and harms of plant-based compounds (PBCs … Comparable THC to CBD Ratio Benefits and Harms Benefits: small improvements in pain severity and … Extracted Whole- Plant High THC to CBD Ratio Benefits and Harms Benefits: insufficient evidence … Tables 3 and 4 summarize benefits and harms of cannabinoids, based on evidence reviewed to date. … We do not anticipate excluding observational studies assessing harms.
  16. effectivehealthcare.ahrq.gov/system/files/docs/headaches-pregnancy-topic-brief.pdf
    January 01, 2019 - What are the harms, effectiveness, and comparative effectiveness and harms of treatments for headache … None of these reported on effectiveness, all outcomes were maternal and fetal safety and harms. … KQ2 (Harms of migraine therapy) is feasible; effectiveness is not feasible. … Medications in pregnancy may cause fetal and infant harms. 2b. … Incorporates issues around both clinical benefits and potential clinical harms Yes 2e.
  17. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - Harms need to be considered in order to determine the balance of benefits to harms. … We cannot consider only the efficacy of these agents but also need to consider their harms. … Outcome — What are the benefits and harms being evaluated? … What are the benefits and harms being evaluated? T is for timing. What is the followup time? … Given the paucity of harms data, could harms data from patients without cystic fibrosis be used to inform
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
    September 24, 2024 - of the Review This systematic review will assess the effectiveness, comparative effectiveness, and harms … Do harms vary by blood or urine chemistry or genetic testing performed as followup after treatment is … KQ 4: What are the comparative harms of surveillance imaging strategies in nonpregnant children and … Do harms vary with preventive treatment? b. Do harms vary by timing of imaging? … Other subgroups of interest include those defined by age (to examine whether the benefits and harms
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
    October 01, 2023 - of patients and/or family members in reporting and/or reducing patient safety events and associated harms … What is the frequency and severity of harms addressed by the patient and family engagement PSPs? … for the patient and family engagement PSPs that have been used to prevent, report or mitigate the harms … We answered Review Questions 1 and 2 by focusing on the harms and patient safety measures or indicators … What Are the Frequency and Severity of Harms Addressed by the Patient and Family Engagement PSPs?
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
    April 25, 2013 - agents across diverse populations over more than a decade, the potential mechanism of action for the harms … not inform the mechanism of action or clearly identify which patients will experience benefits or harms … The authors may consider the following regarding this statement: 1)- state what the specific harms are … There is a plausible explanation of harms based on thromboembolic complications. … A discussion of REMS as it applies to benefits and harms is beyond the scope of this report.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: